Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

PRLD | Prelude Therapeutics Inc

IndexRUT P/E- EPS (ttm)-2.35 Insider Own54.09% Shs Outstand36.50M Perf Week-13.25%
Market Cap150.73M Forward P/E- EPS next Y-2.09 Insider Trans6.26% Shs Float25.16M Perf Month-23.18%
Income-116.75M PEG- EPS next Q-0.58 Inst Own45.94% Short Float / Ratio6.84% / 13.91 Perf Quarter-38.20%
Sales0.00M P/S- EPS this Y5.12% Inst Trans-2.05% Short Interest1.72M Perf Half Y-57.30%
Book/sh4.78 P/B0.58 EPS next Y9.72% ROA-43.27% Target Price8.25 Perf Year-59.32%
Cash/sh4.65 P/C0.59 EPS next 5Y- ROE-46.43% 52W Range2.66 - 8.66 Perf YTD-54.47%
Dividend- P/FCF- EPS past 5Y-64.12% ROI-44.55% 52W High-68.26% Beta0.43
Dividend %- Quick Ratio17.13 Sales past 5Y0.00% Gross Margin- 52W Low3.38% ATR0.25
Employees122 Current Ratio17.13 Sales Q/Q- Oper. Margin0.00% RSI (14)25.90 Volatility7.05% 7.75%
OptionableYes Debt/Eq0.00 EPS Q/Q6.55% Profit Margin- Rel Volume0.79 Prev Close2.81
ShortableYes LT Debt/Eq0.00 EarningsAug 03 BMO Payout- Avg Volume123.78K Price2.75
Recom2.75 SMA20-20.07% SMA50-25.84% SMA200-48.26% Volume47,863 Change-2.14%
Date Action Analyst Rating Change Price Target Change
Nov-21-22Downgrade BofA Securities Neutral → Underperform $8 → $6
Sep-09-22Downgrade Morgan Stanley Overweight → Equal-Weight $19 → $11
Jul-29-22Initiated Jefferies Buy $9
Mar-15-22Downgrade BofA Securities Buy → Neutral $50 → $10
Feb-28-22Downgrade Barclays Overweight → Equal Weight $20 → $12
Oct-08-21Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-27-21Upgrade BofA Securities Neutral → Buy $60
Apr-26-21Initiated H.C. Wainwright Buy $62
Mar-09-21Initiated Barclays Overweight $80
Nov-20-20Downgrade BofA Securities Buy → Neutral $40 → $60
Oct-20-20Initiated BofA Securities Buy $40
Aug-29-23 08:30AM
Aug-17-23 09:56AM
Aug-03-23 08:00AM
Jul-10-23 08:13AM
Jun-02-23 11:36AM
08:30AM Loading…
May-31-23 08:30AM
May-28-23 08:11AM
May-18-23 07:00AM
May-17-23 04:08PM
May-08-23 08:30AM
Apr-27-23 08:30AM
Apr-11-23 08:30AM
Apr-07-23 09:34AM
Mar-18-23 06:48PM
Mar-16-23 12:06PM
08:30AM Loading…
Mar-15-23 08:30AM
Mar-01-23 08:30AM
Feb-09-23 09:05AM
Jan-30-23 09:38AM
Dec-24-22 07:05AM
Nov-25-22 08:06AM
Nov-14-22 08:00AM
Oct-18-22 08:00AM
Sep-06-22 08:00AM
Aug-23-22 06:39AM
Aug-10-22 09:25AM
Aug-09-22 08:00AM
Jul-05-22 09:22PM
Jun-22-22 09:55AM
06:35AM Loading…
May-25-22 06:35AM
May-10-22 08:00AM
Mar-16-22 07:30AM
Mar-11-22 08:00AM
Mar-09-22 08:05AM
Feb-11-22 07:00AM
Jan-04-22 07:00AM
Dec-24-21 12:38AM
Dec-18-21 12:38AM
Dec-16-21 09:41AM
Dec-15-21 07:15PM
Dec-08-21 08:47AM
Nov-23-21 07:00AM
Nov-19-21 11:51AM
Nov-12-21 08:00AM
Nov-08-21 09:00AM
Oct-18-21 08:24PM
Oct-07-21 03:12PM
Sep-25-21 10:06AM
Sep-09-21 07:07PM
Sep-02-21 07:00AM
Aug-12-21 07:30AM
Aug-11-21 06:49AM
Jul-19-21 07:00AM
May-13-21 07:15AM
May-11-21 07:30AM
May-05-21 07:00AM
Apr-20-21 07:42AM
Mar-16-21 08:00AM
Mar-03-21 07:00AM
Jan-11-21 06:20PM
Jan-07-21 12:12AM
Jan-04-21 04:16PM
Dec-25-20 04:01AM
Dec-15-20 11:42PM
Nov-10-20 07:30AM
Oct-02-20 08:00PM
Oct-01-20 11:57AM
Sep-30-20 07:00AM
Sep-29-20 04:05PM
Sep-25-20 02:31PM
Sep-24-20 08:50PM
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vaddi KrishnaCEOMay 25Buy5.319004,7791,067,275May 26 04:20 PM
Lim Bryant DavidChief Legal Officer, Corp Sec.May 24Buy5.392,40012,9362,400May 25 04:07 PM
Vaddi KrishnaCEOMay 24Buy5.011,0005,0111,066,375May 26 04:20 PM
Vaddi KrishnaCEOMay 23Buy5.6311,85666,7491,065,375May 25 04:03 PM
Chardonnet LaurentChief Financial OfficerMay 23Buy5.505,00027,50042,165May 25 04:05 PM
ORBIMED ADVISORS LLCDirectorMay 22Buy5.75869,5654,999,99910,119,756May 24 05:09 PM
Bonita David PDirectorMay 22Buy5.75869,5654,999,99910,119,756May 24 05:07 PM
Huang JanePresident, CMOApr 06Sale6.1213,28081,27424,220Apr 06 06:19 PM
Vaddi KrishnaCEODec 20Buy5.1319,18898,446120,665Dec 21 04:08 PM
Chardonnet LaurentChief Financial OfficerDec 08Buy4.7610,00047,60035,873Dec 12 09:13 AM